Asgard Therapeutics’ Financing Round

Roschier represented RV Invest and Johnson & Johnson Innovation on the deal.Asgard Therapeutics AB, a Swedish biotech company pioneering in vivo direct cell reprogramming for cancer…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Maha Kanaan

Author: Maha Kanaan

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here